PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21223737-0	2010	[Influence of arsenic trioxide and daunorubicin on the expression of annexin II and fibrinolytic activity in NB4 cells].	Daunorubicin	35-47	annexin A2	Homo sapiens	69-79	
21223737-1	2010	OBJECTIVE: To study the expression of annexin II (AnnII) and the fibrinolytic activity in NB4 cells and their alterations in the presence of arsenic trioxide (ATO) and daunorubicin (DNR).	Daunorubicin	168-180	annexin A2	Homo sapiens	50-55	
21223737-1	2010	OBJECTIVE: To study the expression of annexin II (AnnII) and the fibrinolytic activity in NB4 cells and their alterations in the presence of arsenic trioxide (ATO) and daunorubicin (DNR).	Daunorubicin	182-185	annexin A2	Homo sapiens	38-48	
21223737-2	2010	METHODS: Leukemia cell line NB4 was treated with ATO or DNR for 24 ~ 72 h. Cell surface expression of AnnII and its mRNA were analysed by flow cytometry and real time PCR, respectively, the fibrinolytic activity by chromogenic assay.	Daunorubicin	56-59	annexin A2	Homo sapiens	102-107	
34049223-10	2021	Finally, we validated Daunorubicin in a 3D transendothelial migration system and also in a in vivo model of advanced EC, demonstrating the ability of Daunorubicin to inhibit the proliferation of ANXA2-overexpressing tumor cells.	Daunorubicin	22-34	annexin A2	Homo sapiens	195-200	
34049223-10	2021	Finally, we validated Daunorubicin in a 3D transendothelial migration system and also in a in vivo model of advanced EC, demonstrating the ability of Daunorubicin to inhibit the proliferation of ANXA2-overexpressing tumor cells.	Daunorubicin	150-162	annexin A2	Homo sapiens	195-200